Advent International pursues further Australia, New Zealand healthcare deals
Private-equity firm Advent International agreed to acquire a controlling stake in New Zealand Clinical Research from existing shareholders including Auckland-based Waterman Capital in a deal that valued the clinical-research network at…
2026-09-02 · 3 MIN READ